Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Conditions: Cancer; Melanoma (Skin); Melanoma, Uveal; Melanoma, Ocular; Bladder Cancer; Mismatch Repair Deficiency; Microsatellite Instability; Non-melanoma Skin Cancer Interventions: Biological: RP1; Biological: nivolumab Sponsor: Replimune Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Melanoma | Skin | Skin Cancer | Study | Uveal Melanoma